Nanoparticles have exceptional properties that make them outstanding candidates for improving diagnostics and the treatment of infectious disease. Their small size, distinctive intrinsic properties, and ability to be decorated with a variety of complex functionalities make them uniquely capable of detection and targeting of certain diseases. Nanotechnology has the ability to increase the sensitivity of detection methods, the potency and ease of treatment, and the effectiveness of vaccinations. However, major challenges remain to their application in low-resource settings due in large part to the sensitivity of these particles to their local environment, a property that makes them both exceptional for detection and prone to complications or failure during synthesis and utilization. These challenges are likely to be solved only by continued and enhanced communication across scientific disciplines, for example, medical doctors and diagnosticians providing information about what is needed in new technologies. This information will enable materials scientists and engineers to rapidly address the corresponding technical challenges, such as the scalable and reproducible generation of nontoxic and stable, yet responsible nanoparticles.
|Original language||English (US)|
|Number of pages||4|
|Journal||ACS Infectious Diseases|
|State||Published - Oct 12 2018|
Bibliographical noteFunding Information:
This work was supported by an NIH Chemistry−Biology Interface Training Grant 5T32GM008700-18 (S.L.M.), the University of Minnesota, and the National Science Foundation under the Center for Sustainable Nanotechnology, CHE-1503408. The CSN is part of the Centers for Chemical Innovation Program.
This work was supported by an NIH Chemistry-Biology Interface Training Grant 5T32GM008700-18 (S.L.M.), the University of Minnesota and theNational Science Foundation under the Center for Sustainable Nanotechnology, CHE-1503408. The CSN is part of the Centers for Chemical Innovation Program.
© 2018 American Chemical Society.